Search Results for:
-
Financings Roundup
Acadia Pharmaceuticals Inc., of San Diego, completed its public offering of 9.2 million shares, including 1.2 million shares sold to cover overallotments, priced at $12.50 per share, for gross proceeds of $115 million...Ironwood Pharmaceuticals Inc., of Cambridge, Mass., said it commenced a public offering of 10.5 million shares of its Class A common stock...NPS Pharmaceuticals Inc., of Bedminster, N.J., is commencing a public offering of 6 million shares of common stock -
Other News To Note
Baliopharm GmbH, a subsidiary of Baliopharm AG, of Basel, Switzerland, joined the NEU2 Consortium with a project addressing the recombinant manufacturing of an Fc-free bispecific CD20-CD95 antibody construct (Novotarg) with selectivity for activated B cells and efficacy studies in disease models relevant to multiple sclerosis therapy. The two-year project was funded by the German Federal Ministry of Education and Research. Bayer AG, of Leverkusen, Germany, signed an agreement to acquire the -
A&G Pharmaceutical Inc.
-
Aarden Pharmaceuticals Inc.
-
Acadia Pharmaceuticals Inc.
-
Access Pharmaceuticals Inc.
-
AcelRx Pharmaceuticals Inc.
-
Acetylon Pharmaceuticals Inc.
-
Achillion Pharmaceuticals Inc.
-
Adamas Pharmaceuticals Inc.
-
Aegerion Pharmaceuticals Inc.
-
Aeolus Pharmaceuticals Inc.
-
Aerie Pharmaceuticals Inc.
-
Afferent Pharmaceuticals Inc.
-
Affinium Pharmaceuticals Inc.
-
Agios Pharmaceuticals Inc.
-
Aida Pharmaceuticals Inc.
-
Alexion Pharmaceuticals Inc.
-
Alexza Pharmaceuticals Inc.
-
Allele Biotechnology and Pharmaceuticals Inc.
Category
Current Filters
- xPharmaceuticals Inc
Related Keywords
Categories
- x BioWorld Today (14055)
- x BioWorld Insight (3037)
- x BioWorld International (709)
- x Bio Perspectives (323)
- x State of the Industry Report (316)
- x Bioscan (213)
- x BioWorld Genomics Review (148)
- x BioWorld Phase III Report (139)
- x Executive Compensation Report (105)
- x BioWorld Snapshots (86)
- x Top 25 Drug Report (52)
- x Biotech Innovations (32)
- x Market-Leading Biotech Drugs (8)
- x RNAi Report (5)